verapamil has been researched along with tallimustine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Broggini, M; Capolongo, L; Grandi, M; Melegaro, G; Mongelli, N | 1 |
| Animati, F; Bigioni, M; Lombardi, P; Manzini, S; Palma, C; Pratesi, G; Salvatore, C; Supino, R; Zunino, F | 1 |
2 other study(ies) available for verapamil and tallimustine
| Article | Year |
|---|---|
Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517).
Topics: Adenocarcinoma; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Colonic Neoplasms; Distamycins; Drug Resistance; Humans; Membrane Glycoproteins; Nitrogen Mustard Compounds; Tumor Cells, Cultured; Verapamil | 1993 |
Cytotoxic and antitumor activity of MEN 10710, a novel alkylating derivative of distamycin.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Calcium Channel Blockers; Cell Survival; Distamycins; Humans; Leukemia L1210; Melphalan; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Neoplastic Stem Cells; Nitrogen Mustard Compounds; Organ Size; Tumor Cells, Cultured; Verapamil | 1997 |